[Terlipressin for hepatorenal syndrome - what is the role of plasma expansion and hemodynamic monitoring?]

[Article in German]

Affiliations

Comment

[Article in German]

A Umgelter et al. Z Gastroenterol. 2009 Mar.

. 2009 Mar;47(3):307-8.

doi: 10.1055/s-0028-1109113. Epub 2009 Mar 11.

¹ II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München.

No abstract available

Comment on

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P; TAHRS Investigators. Martín-Llahí M, et al. Gastroenterology. 2008 May;134(5):1352-9. doi: 10.1053/j.gastro.2008.02.024. Epub 2008 Feb 14. Gastroenterology. 2008. PMID: 18471512 Clinical Trial.
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P; Terlipressin Study Group. Sanyal AJ, et al. Gastroenterology. 2008 May;134(5):1360-8. doi: 10.1053/j.gastro.2008.02.014. Epub 2008 Feb 13. Gastroenterology. 2008. PMID: 18471513 Free PMC article. Clinical Trial.